Skip to main content

Phototherapy in Hand Dermatitis

  • Chapter
  • First Online:
Textbook of Hand Eczema

Abstract

Although the majority of chronic hand dermatitis can successfully be managed by dry skin care, contact avoidance, and topical steroidal or nonsteroidal therapies, phototherapy remains a useful adjunctive tool for the management of recalcitrant cases. Phototherapy, irradiation with ultraviolet light (UV), is administered via one of several modalities: UVA (400–320 nm), UVA-1 (400–340 nm), PUVA (psoralen plus UVA), UVB (320–270 nm), narrowband UVB (313–308 nm), or monochromatic excimer light (308 nm). At present, PUVA remains the most investigated type of phototherapy and the standard for comparison. UVA-1 and the various UVB therapies may offer comparable clinical improvements to PUVA therapy. A recent development is the availability of home oral PUVA and UVB therapies, which offer similar therapeutic benefits to clinically administered therapy with less disruption of the patient’s daily activities. Relapse rates are high for all phototherapy subtypes, but less frequent maintenance treatments may aid in sustaining continued clearance. Despite this high frequency of relapse, phototherapy is a useful adjunctive treatment option for recalcitrant chronic hand dermatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    For the purpose of this chapter, treatment-resistant/recalcitrant, chronic hand dermatitis (CHD) is defined as an eczematous dermatitis (atopic, dyshidrotic, hyperkeratotic, nummular, allergic contact, or irritant contact dermatitis) limited to the hands and feet that has persisted for greater than 6 months without two continuous weeks of clearance despite adequate contact avoidance, dry skin care, and topical therapy (steroidal and nonsteroidal immunomodulatory agents) [3].

References

  1. Roelandts R. The history of phototherapy: something new under the sun? J Am Acad Dermatol. 2002;46(6):926–30.

    Article  PubMed  Google Scholar 

  2. Pacifico A, Leone G. Photo (chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed. 2011;27(5):261–77.

    Article  CAS  PubMed  Google Scholar 

  3. Diepgen T, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4):203–10.

    Article  PubMed  Google Scholar 

  4. van Coevorden A, Kamphof W, Sonderen E, Bruynzeel D, Coenraads P. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs. hospital-administered bath psoralen-UV-A in patients with chronic hand eczema. Arch Dermatol. 2004;140(12):1463–6.

    PubMed  Google Scholar 

  5. Sjovall P, Christensen O. Treatment of chronic hand eczema with UV-B Handylux in the clinic and at home. Contact Dermatitis. 1994;31(1):5–8.

    Article  CAS  PubMed  Google Scholar 

  6. WHO International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans [Internet]. 2012. Available from http://monographs.iarc.fr/ENG/Classification/index.php

  7. de With A, Greulich K. Wavelength dependence of laser-induced DNA damage in lymphocytes observed by single-cell gel electrophoresis. J Photochem Photobiol B. 1995;30:71–6.

    Article  PubMed  Google Scholar 

  8. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maitre M. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systemic literature review. J Eur Acad Dermatol Venereol. 2012;26 Suppl 3:22–31.

    Article  CAS  PubMed  Google Scholar 

  9. Man I, Crombie I, Dawe R, Ibbotson S, Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2005;152(4):755–7.

    Article  CAS  PubMed  Google Scholar 

  10. Flindt-Hansen H, McFadden N, Eeg-Larson T, Thune P. Effects of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol. 1991;71(3):245–8.

    CAS  PubMed  Google Scholar 

  11. Gibbs N, Traynor N, MacKie R, Campbell I, Johnson B, Ferguson J. The phototumorigenic potential of broad-band (270–250 nm) and narrow-band (311–313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol. 1995;104(3):359–63.

    Article  CAS  PubMed  Google Scholar 

  12. Grattan C, Carmichael A, Shuttleworth G, Foulds I. Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol. 1991;71(2):118–22.

    CAS  PubMed  Google Scholar 

  13. Engin B, Oguz O. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. Int J Dermatol. 2005;44(4):337–9.

    Article  CAS  PubMed  Google Scholar 

  14. Petering H, Breuer C, Herbst R, Kapp A, Werfel T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol. 2004;50(1):68–72.

    Article  PubMed  Google Scholar 

  15. Polderman M, Govaert J, Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol. 2003;28(6):584–7.

    Article  CAS  PubMed  Google Scholar 

  16. Tuchinda C, Kerr H, Taylor C, Jacobe H, Bergamo B, Elmets C, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed. 2006;22(5):247–53.

    Article  PubMed  Google Scholar 

  17. Morison W, Parrish J, Fitzpatrick T. Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles. Br J Dermatol. 1978;99(3):297–302.

    Article  Google Scholar 

  18. LeVine M, Parrish J, Fitzpatrick T. Oral methoxsalen photochemotherapy (PUVA) of dyshidrotic eczema. Acta Derm Venereol. 1981;61(6):570–1.

    CAS  PubMed  Google Scholar 

  19. Tegner E, Thelin I. PUVA treatment of chronic eczematous dermatitis of the palms and soles. Acta Derm Venereol. 1985;65(5):451–3.

    CAS  PubMed  Google Scholar 

  20. Hawk J, Grice P. The efficacy of localized PUVA therapy for chronic hand and foot dermatoses. Clin Exp Dermatol. 1994;19(6):479–82.

    Article  CAS  PubMed  Google Scholar 

  21. Tzameva S, Kittler H, Thallinger C, Honigsmann H, Tanew A. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed. 2009;25(2):101–5.

    Article  Google Scholar 

  22. Sheehan-Dare R, Goodfield M, Rowell N. Topical psoralen photochemotherapy (PUVA) and superficial radiotherapy in the treatment of chronic hand eczema. Br J Dermatol. 1989;121(1):65–9.

    Article  CAS  PubMed  Google Scholar 

  23. De Rie M, Van Eendenburg JP, Versnick A, Stolk L, Bos J, Westerhof W. A new psoralen-containing gel for topical PUVA therapy: development and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. Br J Dermatol. 1995;132(6):964–9.

    Article  PubMed  Google Scholar 

  24. Schempp C, Muller H, Czech W, Schopf E, Simon J. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997;36(5 Part I):733–7.

    Article  CAS  PubMed  Google Scholar 

  25. Gritiyarangsan P, Sukhum A, Tresukosol P, Kullavanijaya P. Topical PUVA therapy for chronic hand eczema. J Dermatol. 1998;25(5):299–301.

    CAS  PubMed  Google Scholar 

  26. Davis M, McEvoy M, El-Azhary R. Topical psoralen-ultraviolet a therapy for palmoplantar dermatoses: experience with 35 consecutive patients. Mayo Clin Proc. 1998;73(5):407–11.

    Article  CAS  PubMed  Google Scholar 

  27. Shephard S, Schregenberger N, Dummer R, Panizzon R. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy. Dermatology. 1998;197(1):25–30.

    Article  CAS  PubMed  Google Scholar 

  28. Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed. 1999;15(2):47–51.

    Article  CAS  PubMed  Google Scholar 

  29. Grundmann-Kollman M, Behrens S, Peter R, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed. 1999;15(2):87–9.

    Article  Google Scholar 

  30. Taylor C, Baron E. Hand and foot PUVA soaks: an audit of the Massachusetts General Hospital’s experience from 1994 to 1998. Photodermatol Photoimmunol Photomed. 1999;15(5):188–92.

    Article  CAS  PubMed  Google Scholar 

  31. Schiener R, Gottlober P, Muller B, Williams S, Pillekamp H, Peter R, et al. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses A randomized, single-blinded prospective study. Photodermatol Photoimmunol Photomed. 2005;21(2):62–7.

    Article  CAS  PubMed  Google Scholar 

  32. Rosen K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol. 1987;67(1):48–54.

    CAS  PubMed  Google Scholar 

  33. Simons J, Bohnen I, van der Valk P. A left-right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks’ treatment. Clin Exp Dermatol. 1997;22(1):7–10.

    Article  CAS  PubMed  Google Scholar 

  34. Nordal E, Christensen O. Treatment of chronic hand dermatoses with UVB-TL01. Acta Derm Venereol. 2004;84(4):302–4.

    Article  PubMed  Google Scholar 

  35. Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed. 2007;23(1):10–4.

    Article  PubMed  Google Scholar 

  36. Jensen L, Stensgaard A, Andersen K. Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses. Dermatol Rep. 2012;4(1):e3.

    Article  Google Scholar 

  37. Aubin F, Vigan M, Puzenat E, Blanc D, Drobacheff C, Deprez P, et al. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol. 2005;152(1):99–103.

    Article  CAS  PubMed  Google Scholar 

  38. Beitner H. Clinical and experimental aspects of long-wave ultraviolet (UVA) irradiation of human skin. Acta Derm Venereol Suppl (Stockh). 1986;123:1–56.

    CAS  Google Scholar 

  39. Godar D. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol. 1999;112(1):3–12.

    Article  CAS  PubMed  Google Scholar 

  40. Grabbe J, Wlker P, Humke S, Grewe M, Schopf E, Henz B, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol. 1996;107(3):419–22.

    Article  CAS  PubMed  Google Scholar 

  41. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol. 2000;25(7):552–8.

    Article  CAS  PubMed  Google Scholar 

  42. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol. 1998;78(4):318–9.

    Article  CAS  PubMed  Google Scholar 

  43. Bethea D, Fullmer B, Syed S, Seltzer G, Tiano J, Rischko C, et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. J Dermatol Sci. 1999;19(2):78–88.

    CAS  PubMed  Google Scholar 

  44. Behrens-Williams S, Gruss C, Grundmann-Kollmann M, Peter R, Kerscher M. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days. Br J Dermatol. 2000;142(1):112–5.

    Article  CAS  PubMed  Google Scholar 

  45. Ibbotson S, Farr P. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol. 1999;113(3):346–50.

    Article  CAS  PubMed  Google Scholar 

  46. FDA. Prescribing Information: 8-MOP Capsules [Internet]. 2012. Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/09048slr037_methoxsalen_lbl.pdf

  47. Tanew A, Kipfelsperger T, Seeber A, Radakovic-Fijan S, Honigsmann H. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment. J Am Acad Dermatol. 2001;44(4):638–42.

    Article  CAS  PubMed  Google Scholar 

  48. Grundmann-Kollman M, Leiter U, Behrens S, Gottlober P, Mooser G, Krahn G, et al. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs 8-methoxypsoralen gel-PUVA. Br J Dermatol. 1999;140(5):988–90.

    Article  Google Scholar 

  49. Wainwright NJ, Mac Leod TM, Ferguson J. Bath PUVA – an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater. Photodermatol Photoimmunol Photomed. 1997;13(1–2):17–20.

    Article  CAS  PubMed  Google Scholar 

  50. Coleman W, Lowe N, David M, Halder R. Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high output metal halide. J Am Acad Dermatol. 1989;20:1078–82.

    Article  CAS  PubMed  Google Scholar 

  51. FDA. Drugs@FDA: FDA approved drugs [Internet] 2012. 8-MOP. Available from http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetailsTrisoralen. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

  52. Tzaneva S, Kittler H, Thallinger C, Honigsmann H, Tanew A. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed. 2009;25(2):101–5.

    Article  PubMed  Google Scholar 

  53. Wakelin S, Maibach H, editors. Handbook of systemic drug treatment in dermatology. 1st ed. London: Manson Publishing; 2002. p. 196–200.

    Google Scholar 

  54. Park H, Lee M. Case of leukoderma punctata after topical PUVA treatment. Int J Dermatol. 2004;43(2):138–9.

    Article  PubMed  Google Scholar 

  55. Jekler J, Larko O. UVB phototherapy of atopic dermatitis. Br J Dermatol. 1988;119(6):697–705.

    Article  CAS  PubMed  Google Scholar 

  56. Park K, Murase J. Ultraviolet B (UVB) phototherapy in the treatment of vitiligo. In: Park K, Murase J, editors. Vitiligo – management and therapy. New York: InTech; 2011. p. 69–79.

    Chapter  Google Scholar 

  57. Parrish J, Jaenicke K. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76(5):359–62.

    Article  CAS  PubMed  Google Scholar 

  58. British Photodermatology Group guidelines for PUVA. Br J Dermatol. 1994;130(2):246–55.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Alikhan M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Griffith, J.L., Davis, M.D.P., Alikhan, A. (2014). Phototherapy in Hand Dermatitis. In: Alikhan, A., Lachapelle, JM., Maibach, H. (eds) Textbook of Hand Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39546-8_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39546-8_32

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39545-1

  • Online ISBN: 978-3-642-39546-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics